Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis

Clinical Chemistry

Volumn 42, Issue 4, 1996, Pages 558-563

  Guéchot, Jérôme ^a   Laudat, Antoine ^a   Loria, Alain ^a   Serfaty, Lawrence ^a   Poupon, Raoul ^a   Giboudeau, Jacqueline ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

diagnostic accuracy; liver disease; procollagen III propeptide

Indexed keywords

COLLAGEN TYPE 3; HYALURONIC ACID; PROCOLLAGEN;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROTEIN BLOOD LEVEL;

HEPATITIS C VIRUS;

EID: 0029879030     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.4.558     Document Type: Article

References (33)

1. Iwarson S, Norkrans G, Wejstal R. Hepatitis C: natural history of a unique infection. Clin Infect Dis 1995;20:1361-70.
2. Trinchet JC. Clinical use of serum markers of liver fibrosis in chronic hepatitis. J Hepatol 1995;22 (Suppl 2):89-95.
3. Gressner AM. Activation of proteoglycan synthesis in injured liver - a brief review of molecular and cellular aspects. Eur J Clin Chem Biochem 1994;32:225-37.
4. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992;6:2397-404.
5. Gressner AM, Bachern MG. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis 1990;10:30-46.
6. Nowack H, Olsen BR, Timpl R. Characterization of the amino-terminal segment of type III procollagen. Eur J Biochem 1976;70: 205-16.
7. Niemelä O, Risteli L, Parkkinen J, Risteli J. Purification and characterization of the N-terminal propeptide of human type III procollagen. Biochem J 1985;232:145-50.
8. Engström-Laurent A, Lööf L, Nyberg A, Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985;5: 638-42.
9. Frébourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, Bourreille J. Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 1986;6:392-5.
10. Nyberg A, Engström-Laurent A, Lööf L. Serum hyaluronate in primary biliary cirrhosis - a biochemical marker for progressive liver damage. Hepatology 1988;8:142-6.
11. McCullough AJ, Stassen WN, Wiesner R, Czaja AJ. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity. Hepatology 1987;7:49-54.
12. Trinchet JC, Hartmann DJ, Pateron D, Laarif M, Callard P, Ville G, Beaugrand M. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. J Hepatol 1991;12:139-44.
13. Guéchot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 1994;20: 388-93.
14. Rosman AS, Lieber CS. Diagnostic utility of laboratory tests in alcoholic liver diseases. Clin Chem 1994;40:1641-51.
15. Risteli J, Risteli L. Analysing connective tissue metabolites in human serum. Biomedical, physiological and methodological aspects. J Hepatol 1995;22(Suppl 2):77-81.
16. Schuppan D, Stölzel U, Oesterling C, Somasundaran R. Serum assays for liver fibrosis. J Hepatol 1995;22(Suppl 2):82-8.
17. Camps J, Castilla A, Ruiz J, Civeira MP, Prieto J. Randomized trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effect on inflammation, fibrogenesis and viremia. J Hepatol 1993; 17:390-6.
18. Suou T, Hosho K, Kishimoto Y, Horie Y, Kawasaki H. Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alpha. Hepatology 1995;22:426-31.
19. Guéchot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol 1995;22: 22-6.
20. Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis. J Hepatol 1995;23:145-52.
21. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
22. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [Review]. Clin Chem 1993;39:561-77.
23. Huguet J, Castineiras MJ, Fuentes-Arderiu X. Diagnostic accuracy evaluation using ROC curve analysis. Scand J Clin Lab Invest 1993;53:693-9.
24. Piccinino F, Sagnell E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicenter retrospective study on 68 276 biopsies. J Hepatol 1986;2:165-73.
25. McGill DB, Rakela J, Zinsmeister AR, Ott BG. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400.
26. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;i:523-5.
27. Trinchet JC. Clinical use of serum markers of fibrosis in chronic hepatitis. J Hepatol 1995;22(Suppl 2):89-95.
28. Eriksson S, Fraser JRE, Laurent TC, Pertorf H, Smedsrod B. Endothelial cells are the site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983;144:223-8.
29. Smedsrod B. Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells. Collagen Rel Res 1988;8:375-88.
30. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7 S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology 1994;20:780-7.
31. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, et al. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology 1993;105:475-81.
32. Gibson PR, Fraser JRE, Brown TJ, Finch CF, Jones PA, Colman JC, Dudley FJ. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology 1992; 15:1054-9.
33. Deaciuc IV, Bagby GJ, Lang CH, Spitzer JJ. Hyaluronic acid uptake by the isolated, perfused rat liver: an index of hepatic sinusoidal endothelial cell function. Hepatology 1993;17:266-72.